FORM
Latest research and positioning on FORM. Read the current recommendation, active play details, and the most recent explanation for intraday price action and catalysts to watch.
Recent proof-backed thesis calls
Recent published calls include a sell recommendation tied to a ManpowerGroup (MAN) 10-Q filing and two recommendation fragments noting that provided excerpts were largely cover/header material with limited actionable financial detail.
The provided excerpt is only the cover/header portion of ManpowerGroup’s Form 10-Q for the quarter ended Sep 30, 2025. It confirms filing status and listing details (NYSE: MAN) but includes no financial statements, MD&A, guidance, segment trends, margins, cash flow, or risk-factor updates. As-is, there is no tradable incremental information beyond confirmation that the 10-Q was filed.
Excerpt is only the cover page of ManpowerGroup Inc. (MAN) Form 10-Q for quarter ended June 30, 2025, confirming filing status, exchange listing (NYSE: MAN), and basic registrant details. No financial results, guidance, segment trends, risk factors, or MD&A content is included in the provided text.
Latest market-close explanation
Today’s price action for FORM looks like a technical/momentum-driven breakout on modest volume. No clear fundamental news was found; monitor follow-through volume, filings, options flow, and peer moves to validate the move.
No market-close explanation is available for `FORM` on 2026-07-24 because usable price history was not available. Reason: no_market_data.
Current stance
Current researcher stance: sell. Recommendation is based on a ManpowerGroup (MAN) 10-Q filing referenced as the catalyst source (confidence 0.60).
- sell via MAN 10-Q report for 2025-09-30 from https://www.sec.gov/edgar/search/ (confidence 0.60)
Top authors on this asset
Active and historical ticker theses
Active play: review of a ManpowerGroup (MAN) Form 10-Q for the quarter ended September 30, 2025. The filing contains consolidated balance sheet, income statement, cash flow and shareholders’ equity data for three- and nine-month periods, plus MD&A and notes; key nine-month items include revenues of $13,244.0 million, a net loss of $43.5 million for the nine months ended Sept. 30, 2025, and cash and cash equivalents of $274.6 million as of Sept. 30, 2025.
Unlock full asset monitoring
Scan SEC filings, company announcements, options flow and intraday volume. Watch support near $120.5–121 and resistance near $127.7 for price-confirmation signals.